APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 50 filers reported holding APTINYX INC in Q3 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,872 | -96.9% | 15,000 | -93.0% | 0.00% | – |
Q4 2022 | $60,740 | -25.9% | 212,900 | -4.2% | 0.00% | – |
Q3 2022 | $82,000 | -36.9% | 222,200 | -4.8% | 0.00% | – |
Q2 2022 | $130,000 | -65.7% | 233,400 | +39.7% | 0.00% | -100.0% |
Q1 2022 | $379,000 | -29.3% | 167,100 | -16.8% | 0.00% | 0.0% |
Q4 2021 | $536,000 | -7.4% | 200,800 | -18.9% | 0.00% | -50.0% |
Q3 2021 | $579,000 | -47.4% | 247,500 | -36.3% | 0.00% | -33.3% |
Q2 2021 | $1,100,000 | -41.2% | 388,800 | -37.7% | 0.00% | -40.0% |
Q1 2021 | $1,871,000 | +14.2% | 623,800 | +31.7% | 0.01% | +25.0% |
Q4 2020 | $1,639,000 | +182.6% | 473,600 | +176.2% | 0.00% | +100.0% |
Q3 2020 | $580,000 | +31.5% | 171,500 | +62.1% | 0.00% | +100.0% |
Q2 2020 | $441,000 | +102.3% | 105,800 | +5.0% | 0.00% | 0.0% |
Q1 2020 | $218,000 | -22.7% | 100,800 | +22.0% | 0.00% | 0.0% |
Q4 2019 | $282,000 | -12.7% | 82,600 | -10.8% | 0.00% | 0.0% |
Q3 2019 | $323,000 | +17.9% | 92,600 | +12.8% | 0.00% | 0.0% |
Q2 2019 | $274,000 | – | 82,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
Orbimed Advisors | 538,500 | $300,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |